Is chronic obstructive pulmonary disease a risk factor for death in patients with community acquired pneumonia?

References

• Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017; Available from: http://goldcopd.org.
   Google Scholar
• Mannino DM, Davis KJ, Kiri VA. Chronic obstructive pulmonary disease and hospitalizations for pneumonia in a US cohort. Respir Med. 2009;103:224–229.
   PubMed Web of Science ®Google Scholar
• Rennard SI, Sin DD, Tashkin DP, et al. The relationship among COPD severity, inhaled corticosteroid use, and the risk of pneumonia. Ann Am Thorac Soc. 2015;12:1587–1589.
   PubMed Web of Science ®Google Scholar
• Kew KM, Seniukovich A. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;3:CD010115.
   PubMed Web of Science ®Google Scholar
• Liapikou A, Toumbis M, Torres A. Managing the safety of inhaled corticosteroids in COPD and the risk of pneumonia. Expert Opin Drug Saf. 2015;14:1237–1247.
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128.
   PubMed Web of Science ®Google Scholar
• Wroe PC, Finkelstein JA, Ray GT, et al. Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis. 2012;205:1589–1592.
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Pletz MW, Aliberti S. European respiratory monograph community-acquired pneumonia. Eur Respir Soc. 2014. doi: 10.1183/1025448x.erm6314.
   PubMedGoogle Scholar
• Montull B, Menéndez R, Torres A, et al. Predictors of severe sepsis among patients hospitalized for community-acquired pneumonia. PLoS One. 2016;11:e0145929.
   PubMed Web of Science ®Google Scholar
• Aliberti S, Brambilla AM, Chalmers JD, et al. Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis. Respir Res. 2014;15:27.
   PubMed Web of Science ®Google Scholar
• Loke YK, Kwok CS, Wong JM, et al. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis. Int J Clin Pract. 2013;67:477–487.
   PubMed Web of Science ®Google Scholar
• Jiang HL, Chen HX, Liu W, et al. Is COPD associated with increased mortality and morbidity in hospitalized pneumonia? A systematic review and meta-analysis. Respirology. 2015;20:1046–1054.
   PubMed Web of Science ®Google Scholar
• Dusemund F, Chronis J, Baty F, et al. The outcome of community-acquired pneumonia in patients with chronic lung disease: a case-control study. Swiss Med Wkly. 2014;144:w14013.
   PubMed Web of Science ®Google Scholar
• Ewig S, Birkner N, Strauss R, et al. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax. 2009;64:1062–1069.
   PubMed Web of Science ®Google Scholar
• de Miguel-Díez J, López-de-Andrés A, Hernández-Barrera V, et al. Impact of COPD on outcomes in hospitalized patients with community-acquired pneumonia: analysis of the Spanish national hospital discharge database (2004–2013). Eur J Intern Med. 2017;43:69–76.
   PubMed Web of Science ®Google Scholar
• Neupane B, Walter SD, Krueger P, et al. Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study. BMC Geriatr. 2010;10:22.
   PubMed Web of Science ®Google Scholar
• Molinos L, Clemente MG, Miranda B, et al. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J Infect. 2009;58:417–424.
   PubMed Web of Science ®Google Scholar
• Restrepo MI, Mortensen EM, Pugh JA, et al. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J. 2006;28:346–351.
   PubMed Web of Science ®Google Scholar
• Rello J, Rodriguez A, Torres A, et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J. 2006;27:1210–1216.
   PubMed Web of Science ®Google Scholar
• Braeken DCW, Franssen FME, Schütte H, et al. Increased severity and mortality of CAP in COPD: results from the German Competence Network, CAPNETZ. Chronic Obstr Pulm Dis. 2015;2:131–140.
   PubMed Web of Science ®Google Scholar
• Liapikou A, Polverino E, Ewig S, et al. Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients. Eur Respir J. 2012;39:855–861.
   PubMed Web of Science ®Google Scholar
• Snijders D, van der Eerden M, de Graaff C, et al. The influence of COPD on mortality and severity scoring in community-acquired pneumonia. Respiration. 2010;79:46–53.
   PubMed Web of Science ®Google Scholar
• Luna CM, Palma I, Niederman MS, et al. The impact of age and comorbidities on the mortality of patients of different age groups admitted with community-acquired pneumonia. Ann Am Thorac Soc. 2016;13:1519–1526.
   PubMed Web of Science ®Google Scholar
• Pifarre R, Falguera M, Vicente-de-Vera C, et al. Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir Med. 2007;101:2139–2144.
   PubMed Web of Science ®Google Scholar
• Crisafulli E, Menéndez R, Huerta A, et al. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD. Chest. 2013;143:1009–1017.
   PubMed Web of Science ®Google Scholar
• Gómez-Junyent J, Garcia-Vidal C, Viasus D, et al. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. PLoS One. 2014;9:e105854.
   PubMed Web of Science ®Google Scholar
• Lim WS, Lewis S, Macfarlane JT. Severity prediction rules in community acquired pneumonia: a validation study. Thorax. 2000;55:219–223.
   PubMed Web of Science ®Google Scholar
• Fujiki R, Kawayama T, Ueyama T, et al. The risk factors for mortality of community-acquired pneumonia in Japan. J Infect Chemother. 2007;13:157–165.
   PubMedGoogle Scholar
• Egelund GB, Jensen AV, Andersen SB, et al. Penicillin treatment for patients with Community-Acquired Pneumonia in Denmark: a retrospective cohort study. BMC Pulm Med. 2017;17:66.
   PubMed Web of Science ®Google Scholar
• Gönen Mihat. 2007. Analyzing receiver operating charateristics curves with SAS^®. Cay (NC): SAS Institute INC.
   Google Scholar
• Braeken DCW, Franssen FME, von Baum H, et al. Bacterial aetiology and mortality in COPD patients with CAP: results from the German Competence Network, CAPNETZ. Int J Tuberc Lung Dis. 2017;21:236–243.
   Google Scholar
• Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313:677–686.
   PubMed Web of Science ®Google Scholar